glutathione mutations in sclc patients

glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Tumor suppressor genes and KRAS

Name: glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Tumor suppressor genes and KRAS
Brand: creatorsinfotech.com
SKU: 66077133301
Price: 24.29 USD
Availability: InStock
Rating: 4.063 (30 reviews)

Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience Glutathione Dependent Pathways in Cancer Cells Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link Oncology Letters The changing treatment landscape of EGFR mutant non small cell lung cancer Nature Reviews Clinical Oncology

SKU: 66077133301 · From creatorsinfotech.com

4.1

USD24.29 USD52.29

Pay in 4 interest-free payments of $6.07 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 12 - Oct 17

Description

Kolarow R, Brigadski T, Lessmann V (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening